相关实验视频
Updated: Jan 7, 2026

03:48
Restraint to Induce Stress in Mice and Rats
Published on: December 6, 2024
3.0K
丁林被皮质调节,并参与其压力反应
Truyen D Pham1, Delaney C Abood1, Eric Delpire2
1Renal Division, Emory University School of Medicine, W.M.B. Room 338, 101 Woodruff Circle, Atlanta, GA 30322.
American journal of physiology. Renal physiology
|December 26, 2025
概括
葡萄糖皮质类药物通过激活矿物质皮质类受体 (MR) 来增加参与血压调节的蛋白质潘德林. 这一过程有助于高血压,特别是在诸如库辛综合征这样的疾病中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- NaCl 限制通过多和矿物皮质皮质体受体 (MR) 在间隔细胞 (IC) 中的激活来调节.
- 11βHSD2酶增强了阿尔多与MR的结合,但其在林调节中的作用尚不清楚.
研究的目的:
- 研究MR和葡萄皮质激素在调节氨酸丰度和亚细胞分布中的作用.
- 为了确定pendrin是否有助于葡萄糖皮质激素诱导的高血压.
主要方法:
- 利用11βHSD2淘汰老鼠和阿尔多合成酶淘汰老鼠来研究MR调节.
- 在 adrenalectomized小鼠中使用IC MR的基因切除和施用皮质.
- 研究了对不同剂量的皮质激素的反应中的林表达和亚细胞局部化.
- 用皮质子治疗的野生类型和林敲击小鼠的评估血压.
主要成果:
- 在11βHSD2淘汰的老鼠中,德林的丰度增加了,这表明MR调节独立于阿尔多.
- MR 抗和 IC MR 基因切除降低了潘德林的丰度.
- 皮质类固醇以剂量依赖的方式调高了林,增加了总蛋白质,并导致亚细胞再分配.
- 皮质在DCT2中增加了氨酸阳性细胞数,在野生型小鼠中增加了血压,但在氨酸淘汰中没有.
结论:
- 葡萄糖皮质类药物通过依赖MR的途径上调丁,增加蛋白质的丰富性并改变亚细胞分布.
- 潘德林上调,特别是在DCT2中,有助于葡萄糖皮质激素诱导的高血压,正如在库辛综合征模型中所见.
相关概念视频
Hypothalamic-Pituitary Axis
65.3K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
65.3K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Physiological Foundation of Stress
507
Stress triggers a coordinated physiological response involving the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. This dual activation ensures that the body is prepared for both immediate and prolonged stress management. The process begins with the perception of a stressor. This initial phase activates the SNS, leading to the rapid release of adrenaline (epinephrine) from the adrenal glands.
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Role of the Sympathetic Nervous System
Adrenaline triggers the...
507
Hormonal Regulation of Blood Pressure
5.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.8K
GPCR Desensitization
7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Adrenergic Receptors: β Subtype
3.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.4K

